サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1372540

米国デジタル薬局市場規模・予測、地域シェア、動向、成長機会分析対象：医薬品タイプ別、製品別、プラットフォーム別、性別

US Digital Pharmacy Market Size and Forecast (2020-2030), Regional Share, Trends, and Growth Opportunity Analysis Coverage: by Drug Type (Prescription Medicine and Over-the-Counter Medicine), Product, Platform, and Gender (Male and Female)
出版日: | 発行: The Insight Partners | ページ情報: 英文 100 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
米国デジタル薬局市場規模・予測、地域シェア、動向、成長機会分析対象：医薬品タイプ別、製品別、プラットフォーム別、性別
出版日: 2023年09月27日
発行: The Insight Partners
ページ情報: 英文 100 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国のデジタル薬局市場は、2022年の672億4,200万米ドルから2030年には2,402億1,600万米ドルに成長すると予測されており、2022年から2030年までのCAGRは17.25%と予想されています。COVID-19パンデミック時の処方薬のオンライン購入の急増とオンラインプラットフォームへの傾斜の増加は、米国のデジタル薬局市場の成長を促進するいくつかの要因です。

血糖値のモニタリングは糖尿病管理の重要な部分です。血糖モニタリングには、グルコメーターまたは血糖測定器が一般的に使用されます。通常、指先を刺して少量の血液を採取し、グルコメーター内のテストストリップに置きます。血糖値は1デシリットル当たりミリグラム（mg/dl）で測定され、安全な血糖値の標準ガイドラインは70～180mg/dlです。

COVID-19パンデミック時の処方薬オンライン購入の急増が米国デジタル薬局市場を促進

ASOP世界財団が2020年に発表した報告書によると、アメリカ国民の50％近くが、利便性とコスト面の利点から医薬品をオンラインで購入しています。Abacus Dataがアメリカの消費者1,500人を対象に実施した別の調査によると、2020年にはアメリカ人の10人に4人（42%）がオンラインで医薬品を購入し、2020年から2021年にかけて医薬品のオンライン購入者数が7%増加することが記録されています。さらに、米国における購入動向から、高血圧、喘息、糖尿病などの慢性的かつ継続的な症状に対して処方される製品（購入全体の23％）から、がん治療薬やホルモン補充療法薬などの特殊な処方薬（それぞれ購入全体の11％）まで、さまざまな処方薬を米国人がオンラインで購入していることがわかる。さらに、64％の人が2021年に初めてオンラインで医薬品を購入しており、パンデミックが終わった後もオンラインでの医薬品購入を継続する意向を示しています。医薬品のオンライン購入が好まれる主な理由は、購入の利便性、商品へのアクセスのしやすさ、処方薬のコスト削減（割引、特別オファーなど）です。healthinsurance.comが実施した調査によると、2021年に米国のメディケア受給者の間で遠隔医療の利用が340％増加しました。増加した利用者の33%は、COVID-19の大流行時にオンライン薬局を通じて処方薬を注文することを好んだと明らかにしました。このように、処方箋薬のオンライン購入に伴うデジタル薬剤師の増加は、急成長するeコマース産業とオンライン購入への消費者行動の大規模なシフトと相まって、米国のデジタル薬局市場の成長に有利です。

市場動向

ウェブベースの統合オンライン薬局インターフェイスが主要動向として浮上

薬剤師と患者がアクセス可能なウェブベースの薬局インターフェースと統合されたeヘルスケアシステムは、今後数年間、米国デジタル薬局市場の新たな動向として浮上する可能性が高いです。オンライン薬局が提供する、医薬品を購入する人々をオンラインでサポートするプログラムは、そのようなインターフェースの顕著な例です。例えば、治療の一環としてスタチンを投与されている患者は、薬の服用を中止したり、不規則な行動をとったりする可能性が高いです。スタチンをベースに処方された医薬品を服用する人々にアドヒアランスサポートを提供する訓練を受けた薬局チームメンバーとのリマインダーやライブチャットは、服用の中止を避けるのに役立ちます。

プラットフォームに基づく洞察

プラットフォームの観点から、米国のデジタル薬局市場はアプリベースとウェブサイトベースに分類されます。アプリベースはさらに、テレヘルス薬局アプリ、投薬管理アプリ、健康・ウェルネスアプリ、調剤薬局アプリ、その他に区分されます。アプリベースのセグメントは2022年に大きな市場シェアを占め、同セグメントは予測期間中に17.60%という高いCAGRを記録すると予測されています。テレヘルス薬局アプリは、2022～2030年の間にアプリベースのセグメントで市場の最大シェアを占めると予想されます。バーチャルヘルスケアは、テレヘルスアプリを通じてどこからでもアクセスできます。2021年に発表されたCDCのデータによると、2020年には成人の37.0%がプロバイダーの訪問、オンライン処方、メンタルヘルスサービスを含む遠隔医療を利用しました。最高の遠隔医療アプリは無料でダウンロードでき、使いやすく、保険サービスを完全にカバーしていることが多いです。テレヘルス薬局アプリのいくつかの例は、Hims &Hers、GoodRx、K Health、Doctor on Demandです。GoodRxは、低コストの訪問、郵送による簡単な処方箋補充、健康保険なしの訪問などのサービスを提供しています。

薬剤の種類によって、米国のデジタル薬局市場は処方薬と市販薬に二分されます。2022年の市場シェアは医療用医薬品が大きく、予測期間中のCAGRは17.83%と予測されます。製品別に見ると、米国のデジタル薬局市場はパーソナルケア、ビタミン＆サプリメント、医薬品＆治療、その他の製品に区分されます。医薬品＆治療セグメントはさらに、セクシャルヘルス、神経障害、ハートケア、糖尿病、減量、その他に分別されます。医薬品・治療分野は2022年に大きな市場シェアを占め、予測期間中に17.87%という高いCAGRを記録すると予測されています。プラットフォームの観点から、米国のデジタル薬局市場はアプリベースとウェブサイトベースに分類されます。アプリベースはさらに、テレヘルス薬局アプリ、投薬管理アプリ、健康・ウェルネスアプリ、調剤薬局アプリ、その他に区分されます。2022年の市場シェアはアプリベースが大きく、同分野は予測期間中に17.60％という高いCAGRを記録すると予測されています。性別では、市場は男性と女性に二分されます。2022年の市場シェアは女性が大きく、予測期間中のCAGRは17.64%と予測されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 米国デジタル薬局市場情勢

  • 概観
  • PEST分析
    • 米国のPEST分析
  • エコシステム分析

第5章 米国デジタル薬局市場- 主要産業力学

  • 主な市場促進要因
    • COVIDパンデミック時の処方薬オンライン購入の急増
  • オンラインプラットフォーム志向の高まり
  • 主な市場抑制要因
    • オンライン薬局運営における不正行為
  • 主な市場機会
    • 技術的に進歩したデジタル薬局ソリューション
  • 今後の動向
    • 統合されたウェブベースのオンライン薬局インターフェース
  • インパクト分析

第6章 米国デジタル薬局市場- 市場分析

  • 米国デジタル薬局市場の売上高、2022年～2030年

第7章 米国デジタル薬局市場米国のデジタル薬局市場- 医薬品タイプ別収益と2030年までの予測

  • 米国デジタル薬局市場の2022年・2030年薬剤タイプ別売上高シェア（%）
  • 処方薬
  • 市販薬

第8章 米国デジタル薬局市場：収益と2030年予測：製品別

  • 米国デジタル薬局市場の2022年・2030年製品別売上高シェア（%）
  • パーソナルケア
  • ビタミン＆サプリメント
  • 医薬品・治療薬
  • その他の製品

第9章 米国デジタル薬局市場：2030年までの収益と予測：プラットフォーム別

  • 米国デジタル薬局市場2022年・2030年プラットフォーム別売上高シェア（%）
  • アプリベース
  • ウェブサイトベース

第10章 米国のデジタル薬局市場-2030年までの収益と予測-性別

  • 米国のデジタル薬局市場、2022年および2030年の男女別売上高シェア（%）
  • 男性
  • 女性

第11章 業界情勢

  • 米国デジタル薬局市場の成長戦略
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • Amazon.com Inc
  • Goodrx Holdings Inc
  • The Cigna Group
  • CVS Health Corp
  • Walmart Inc
  • Hims & Hers Health Inc
  • Roman Health Pharmacy LLC
  • Apex Pharmacy Inc
  • LloydsPharmacy Ltd
  • Pharmacy2U Ltd
  • Docmorris NV
  • Truepill

第13章 付録

図表

List Of Tables

  • Table 1. US Digital Pharmacy Market Segmentation
  • Table 2. List of Vendors in the Value Chain
  • Table 3. Market Share (~) by Companies in the US Digital Pharmacy Market (%)
  • Table 4. Market Share Analysis of Companies, by Telehealth Category
  • Table 5. Organic Developments Done by Companies
  • Table 6. Inorganic Developments Done by Companies
  • Table 7. Glossary of Terms, US Digital Pharmacy Market

List Of Figures

  • Figure 1. Key Insights
  • Figure 2. US - PEST Analysis
  • Figure 3. US Digital Pharmacy Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. US Digital Pharmacy Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. US Digital Pharmacy Market Revenue Share, by Drug Type 2022 & 2030 (%)
  • Figure 7. Prescription Medicine: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Over-the-Counter Medicine: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. US Digital Pharmacy Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 10. Personal Care: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Vitamins & Supplements: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Medicines & Treatments: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Sexual Health: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Premature Ejaculation Treatment: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others Sexual Health Products: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Neurological Disorders: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Heartcare: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Diabetes: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Weight Loss: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. US Digital Pharmacy Market Revenue Share, by Platform 2022 & 2030 (%)
  • Figure 23. App-Based: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Telehealth Pharmacy Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Medication Management Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Health and Wellness Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Compounding Pharmacy Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Other Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Website Based: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. US Digital Pharmacy Market Revenue Share, by Gender 2022 & 2030 (%)
  • Figure 31. Male: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Female: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Growth Strategies in the US Digital Pharmacy Market
目次
Product Code: TIPRE00030057

The US digital pharmacy market is expected to grow from US$ 67.242 billion in 2022 to US$ 240.216 billion by 2030; it is expected to grow at a CAGR of 17.25% from 2022 to 2030. Upsurge in online purchase of prescription medicines during the COVID-19 pandemic and an increasing inclination toward online platforms are a few factors driving the US digital pharmacy market growth.

Monitoring blood sugar is a vital part of diabetes management. A glucometer or blood sugar meter is commonly used for blood glucose monitoring. It involves taking a small drop of blood, usually by pricking the fingertip and placing it on the test strip in a glucometer. Blood sugar levels are measured in milligrams per deciliter (mg/dl), with standard guidelines for safe blood sugar ranging from 70 to 180 mg/dl.

Upsurge in Online Purchase of Prescription Medicines During COVID-19 Pandemic Propels US Digital Pharmacy Market

According to a report published by the ASOP Global Foundation in 2020, nearly 50% of the American population purchased medicines online due to convenience and cost benefits. As per another survey conducted by Abacus Data on 1,500 American consumers, 4 in 10 Americans (42%) purchased medicines online in 2020, recording a 7% rise in the number of online buyers of medicines from 2020 to 2021. Moreover, purchase trends in the US indicate Americans buy an array of prescription drugs online, ranging from products prescribed against chronic and ongoing conditions (23% for all purchases), including high blood pressure, asthma, and diabetes, to specialty prescriptions such as cancer and hormone replacement therapy drugs (each accounting 11% of all purchases). Additionally, 64% of the individuals purchased medicines online for the first time in 2021, with intentions to continue buying online medicine even after the pandemic ends. The preference for online buying of medicines is mainly due to the convenience of buying, accessibility to products, and reduced cost of prescription medication (discounts, special offers, etc.). According to a survey conducted by healthinsurance.com, there was a 340% increase in telemedicine usage among Medicare recipients in the US in 2021. 33% of the increased users revealed that they preferred ordering prescription medicines through an online pharmacy during the COVID-19 pandemic. Thus, an increase in the number of digital pharmacists along with online purchases of prescription medicines, coupled with the rapidly spurring e-commerce industry and a massive shift in consumer behavior toward online purchases, favors the US digital pharmacy market growth.

Market Trend

Integrated Web-Based Online Pharmacy Interface Emerges as Key Trend

Integrated e-healthcare systems incorporated with web-based pharmacy interfaces that are accessible to pharmacists and patients are likely to emerge as new trends in the US digital pharmacy market in the coming years. Programs made available by online pharmacies to provide online support to people buying medicines are a notable example of such interfaces. For instance, patients administered with statins as a part of their treatments are likely to discontinue or show irregularities in taking medicines. Reminders and live chat with a pharmacy team member trained in providing adherence support to people consuming statin-based prescribed medicines can help avoid the discontinuation of doses.

Platform-Based Insights

In terms of platform, the US digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. Telehealth pharmacy apps are expected to account for a maximum share of the market for the app-based segment during 2022-2030. Virtual healthcare can be accessed through telehealth apps from anywhere. According to CDC data published in 2021, 37.0% of adults used telemedicine in 2020, including provider visits, online prescriptions, and mental health services. The best telehealth apps can be downloaded free of cost and are easy to use, and they often completely cover insurance services. A few examples of telehealth pharmacy apps are Hims & Hers, GoodRx, K Health, and Doctor on Demand. GoodRx offers services such as low-cost visits, easy prescription refills via mail, and visits without health insurance.

Based on drug type, the US digital pharmacy market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.83% during the forecast period. Based on product, the US digital pharmacy market is segmented into personal care, vitamins & supplements, medicines & treatments, and other products. The medicine & treatments segment is further segregated as sexual health, neurological disorders, heartcare, diabetes, weight loss, and others. The medicine and treatment segment held a larger market share in 2022, and the segment is anticipated to register a higher CAGR of 17.87% during the forecast period. In terms of platform, the US digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. By gender, the market is bifurcated into males and females. The females segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.64% during the forecast period..

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US digital pharmacy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global US digital pharmacy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth US market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. US Digital Pharmacy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 US PEST Analysis
  • 4.3 Ecosystem Analysis

5. US Digital Pharmacy Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Upsurge in Online Purchase of Prescription Medicines During COVID-19 Pandemic
  • 5.2 Increasing Inclination Towards Online Platform
  • 5.3 Key Market Restraints:
    • 5.3.1 Illicit Practices in Online Pharmacy Operations
  • 5.4 Key Market Opportunities:
    • 5.4.1 Technologically Advanced Digital Pharmacy Solutions
  • 5.5 Future Trends
    • 5.5.1 Integrated Web-Based Online Pharmacy Interface
  • 5.6 Impact Analysis:

6. US Digital Pharmacy Market - Market Analysis

  • 6.1 US Digital Pharmacy Market Revenue (US$ Mn), 2022 - 2030

7. US Digital Pharmacy Market - Revenue and Forecast to 2030 - by Drug Type

  • 7.1 Overview
  • 7.2 US Digital Pharmacy Market Revenue Share, by Drug Type 2022 & 2030 (%)
  • 7.3 Prescription Medicine
    • 7.3.1 Overview
    • 7.3.2 Prescription Medicine: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Over-the-Counter Medicine
    • 7.4.1 Overview
    • 7.4.2 Over-the-Counter Medicine: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)

8. US Digital Pharmacy Market - Revenue and Forecast to 2030 - by Product

  • 8.1 Overview
  • 8.2 US Digital Pharmacy Market Revenue Share, by Product 2022 & 2030 (%)
  • 8.3 Personal Care
    • 8.3.1 Overview
    • 8.3.2 Personal Care: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Vitamins & Supplements
    • 8.4.1 Overview
    • 8.4.2 Vitamins & Supplements: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Medicines & Treatments
    • 8.5.1 Overview
    • 8.5.2 Medicines & Treatments: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.5.3 Sexual Health
      • 8.5.3.1 Overview
    • 8.5.4 Sexual Health: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.5.4.1 Premature Ejaculation Treatment
        • 8.5.4.1.1 Overview
        • 8.5.4.1.2 Premature Ejaculation Treatment: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.5.4.2 Other Sexual Health
        • 8.5.4.2.1 Overview
        • 8.5.4.2.2 Other Sexual Health: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.5.5 Neurological Disorders
      • 8.5.5.1 Overview
      • 8.5.5.2 Neurological Disorders: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.5.6 Heartcare
      • 8.5.6.1 Overview
      • 8.5.6.2 Heartcare: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.5.7 Diabetes
      • 8.5.7.1 Overview
      • 8.5.7.2 Diabetes: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.5.8 Weight Loss
      • 8.5.8.1 Overview
      • 8.5.8.2 Weight Loss: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.5.9 Others
      • 8.5.9.1 Overview
      • 8.5.9.2 Others: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Products
    • 8.6.1 Overview
    • 8.6.2 Others Products: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)

9. US Digital Pharmacy Market - Revenue and Forecast to 2030 - by Platform

  • 9.1 Overview
  • 9.2 US Digital Pharmacy Market Revenue Share, by Platform 2022 & 2030 (%)
  • 9.3 App-Based
    • 9.3.1 Overview
    • 9.3.2 App-Based: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Telehealth Pharmacy Apps
      • 9.3.3.1 Overview
      • 9.3.3.2 Telehealth Pharmacy Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.4 Medication Management Apps
      • 9.3.4.1 Overview
      • 9.3.4.2 Medication Management Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.5 Health and Wellness Apps
      • 9.3.5.1 Overview
      • 9.3.5.2 Health and Wellness Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.6 Compounding Pharmacy Apps
      • 9.3.6.1 Overview
      • 9.3.6.2 Compounding Pharmacy Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.7 Other Apps
      • 9.3.7.1 Overview
      • 9.3.7.2 Other Apps: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Website Based
    • 9.4.1 Overview
    • 9.4.2 Website Based: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)

10. US Digital Pharmacy Market - Revenue and Forecast to 2030 - by Gender

  • 10.1 Overview
  • 10.2 US Digital Pharmacy Market Revenue Share, by Gender 2022 & 2030 (%)
  • 10.3 Male
    • 10.3.1 Overview
    • 10.3.2 Male: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Female
    • 10.4.1 Overview
    • 10.4.2 Female: US Digital Pharmacy Market - Revenue and Forecast to 2030 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the US Digital Pharmacy Market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Amazon.com Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Goodrx Holdings Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 The Cigna Group
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 CVS Health Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Walmart Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Hims & Hers Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Roman Health Pharmacy LLC
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Apex Pharmacy Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 LloydsPharmacy Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Pharmacy2U Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Docmorris NV
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Truepill
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms